From: Investigating the mortality trend of gastrointestinal cancers in Babol, North Iran (2013–2021)
Years | Rate | Esophagus | Stomach | Small Intestine | Colon | Rectosigmoid Junction | Rectum | Anus and Anal Canal | Liver and Intrahepatic Bile Ducts | Gallbladder | Pancreas | Other and Ill-defined Digestive Organs |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2013 | Crude | 2.7 | 9.2 | 2.2 | 3.1 | 0 | 0.2 | 0.2 | 6.3 | 0 | 0.2 | 0 |
Standardized | 2.6 | 7.6 | 1.8 | 2.6 | 0 | 0.2 | 0.2 | 5.1 | 0 | 0.1 | 0 | |
2014 | Crude | 2.3 | 11.0 | 2.7 | 2.1 | 0 | 0.2 | 0 | 4.6 | 0 | 0.2 | 0.4 |
Standardized | 1.8 | 9.0 | 2.1 | 1.5 | 0 | 0.2 | 0 | 4.0 | 0 | 0.2 | 0.3 | |
2015 | Crude | 2.5 | 8.8 | 0.2 | 2.9 | 0 | 1.3 | 0.2 | 1.5 | 0.2 | 2.1 | 0.6 |
Standardized | 1.8 | 7.5 | 0.1 | 2.5 | 0 | 1.2 | 0.2 | 1.3 | 0.2 | 1.7 | 0.4 | |
2016 | Crude | 2.8 | 11.8 | 0.4 | 3.8 | 0.2 | 1.3 | 0 | 2.8 | 0 | 3.9 | 2.3 |
Standardized | 2.1 | 9.7 | 0.3 | 3.1 | 0.1 | 1.1 | 0 | 2.2 | 0 | 3.3 | 1.5 | |
2017 | Crude | 2.4 | 11.1 | 0.4 | 6.3 | 0 | 0 | 0 | 2.4 | 0.2 | 2.2 | 2.8 |
Standardized | 1.9 | 9.3 | 0.3 | 5.2 | 0 | 0 | 0 | 2.1 | 0.2 | 1.7 | 2.5 | |
2018 | Crude | 1.8 | 6.4 | 0.4 | 7.5 | 0.4 | 0.2 | 0.2 | 2.7 | 0.5 | 3.3 | 3.8 |
Standardized | 1.6 | 5.1 | 0.3 | 5.9 | 0.2 | 0.1 | 0.1 | 2.3 | 0.4 | 2.9 | 3.1 | |
2019 | Crude | 1.3 | 14.1 | 0 | 6.3 | 0.4 | 0 | 0.4 | 2.9 | 0.5 | 2.7 | 2.3 |
Standardized | 1.1 | 11.0 | 0 | 5.4 | 0.3 | 0 | 0.3 | 2.4 | 0.4 | 2.7 | 1.8 | |
2020 | Crude | 3.4 | 12.6 | 0.2 | 7.5 | 0.4 | 0 | 0 | 4.8 | 0.5 | 1.8 | 1.1 |
Standardized | 2.7 | 10.1 | 0.2 | 5.9 | 0.4 | 0 | 0 | 4.0 | 0.5 | 1.6 | 1.0 | |
2021 | Crude | 1.2 | 10.9 | 0.4 | 6.1 | 0.4 | 0.5 | 0.2 | 3.2 | 1.1 | 2.8 | 2.8 |
Standardized | 0.9 | 9.2 | 0.3 | 5.5 | 0.3 | 0.5 | 0.2 | 2.6 | 0.9 | 2.7 | 2.4 | |
P-trend | 0.206 | 0.074 | < 0.001 | < 0.001 | 0.019 | 0.144 | 0.699 | 0.163 | < 0.001 | 0.002 | < 0.001 |